Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Oncolytics Biotech Inc.

    NASDAQ: ONCY · Real-Time Price · USD
    0.65
    0.01 (1.48%)
    At close: Jun 17, 2025, 3:42 PM

    Oncolytics Biotech Statistics

    Share Statistics

    Oncolytics Biotech has 88.82M shares outstanding. The number of shares has increased by 13.93% in one year.

    Shares Outstanding

    n/a
    		 88.82M

    Shares Change (YoY)

    n/a
    		 13.93%

    Shares Change (QoQ)

    n/a
    		 12.13%

    Owned by Institutions (%)

    n/a
    		 1.73%

    Shares Floating

    n/a
    		 85.97M

    Failed to Deliver (FTD) Shares

    n/a
    		 14,192

    FTD / Avg. Volume

    n/a
    		 2.25%

    Short Selling Information

    The latest short interest is 2.25M, so 2.54% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.25M

    Short % of Shares Out

    n/a
    		 2.54%

    Short % of Float

    n/a
    		 2.64%

    Short Ratio (days to cover)

    n/a
    		 1.58

    Valuation Ratios

    PE Ratio

    n/a
    		 0

    Forward PE

    n/a
    		 -1.51

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 0

    P/FCF Ratio

    n/a
    		 0

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Oncolytics Biotech.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.82, with a Debt / Equity ratio of 0.18.

    Current Ratio

    n/a
    		 2.82

    Quick Ratio

    n/a
    		 2.82

    Debt / Equity

    n/a
    		 0.18

    Debt / EBITDA

    n/a
    		 -0.03

    Debt / FCF

    n/a
    		 -0.04

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-991,142.86

    Employee Count

    n/a
    		 28

    Asset Turnover

    n/a
    		 n/a

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 97K

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -36.63% in the last 52 weeks. The beta is 1.19, so Oncolytics Biotech's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.19

    52-Week Price Change

    n/a
    		 -36.63%

    50-Day Moving Average

    n/a
    		 0.5

    200-Day Moving Average

    n/a
    		 0.79

    Relative Strength Index (RSI)

    n/a
    		 72.17

    Average Volume (20 Days)

    n/a
    		 630,373

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -403K

    Operating Income

    n/a
    		 -33.79M

    Net Income

    n/a
    		 -27.75M

    EBITDA

    n/a
    		 -33.71M

    EBIT

    n/a
    		 -33.79M

    Earnings Per Share (EPS)

    n/a
    		 -0.41
    Full Income Statement

    Balance Sheet

    The company has 15.94M in cash and 1.06M in debt, giving a net cash position of 14.88M.

    Cash & Cash Equivalents

    n/a
    		 15.94M

    Total Debt

    n/a
    		 1.06M

    Net Cash

    n/a
    		 14.88M

    Retained Earnings

    n/a
    		 -477.71M

    Total Assets

    n/a
    		 20.19M

    Working Capital

    n/a
    		 12.19M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -26.97M and capital expenditures -239K, giving a free cash flow of -27.2M.

    Operating Cash Flow

    n/a
    		 -26.97M

    Capital Expenditures

    n/a
    		 -239K

    Free Cash Flow

    n/a
    		 -27.2M

    FCF Per Share

    n/a
    		 0
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    ONCY does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ONCY is $5, which is 681.2% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $5

    Price Target Difference

    n/a
    		 681.2%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on May 25, 2018. It was a backward split with a ratio of 2:19.

    Last Split Date

    n/a
    		 May 25, 2018

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 2:19

    Scores

    Altman Z-Score

    n/a
    		 -36.77

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist